MA38411A1 - Cdc7 inhibitors - Google Patents

Cdc7 inhibitors

Info

Publication number
MA38411A1
MA38411A1 MA38411A MA38411A MA38411A1 MA 38411 A1 MA38411 A1 MA 38411A1 MA 38411 A MA38411 A MA 38411A MA 38411 A MA38411 A MA 38411A MA 38411 A1 MA38411 A1 MA 38411A1
Authority
MA
Morocco
Prior art keywords
cdc7 inhibitors
cdc7
inhibitors
cancer
useful
Prior art date
Application number
MA38411A
Other languages
French (fr)
Other versions
MA38411B1 (en
Inventor
Timothy Andrew Woods
Robert Dean Dally
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Priority claimed from PCT/US2014/021466 external-priority patent/WO2014143601A1/en
Publication of MA38411A1 publication Critical patent/MA38411A1/en
Publication of MA38411B1 publication Critical patent/MA38411B1/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

La présente invention concerne des composés d'isoindolinone, ou un sel pharmaceutiquement acceptable de ceux-ci, qui inhibent la cdc7 et qui, par conséquent, peuvent être utiles dans le traitement du cancer.The present invention relates to isoindolinone compounds, or a pharmaceutically acceptable salt thereof, that inhibit cdc7 and, therefore, may be useful in the treatment of cancer.

MA38411A 2013-03-14 2014-03-07 Cdc7 inhibitors MA38411B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201361782798P 2013-03-14 2013-03-14
PCT/US2014/021466 WO2014143601A1 (en) 2013-03-14 2014-03-07 CDC7 Inhibitors

Publications (2)

Publication Number Publication Date
MA38411A1 true MA38411A1 (en) 2018-02-28
MA38411B1 MA38411B1 (en) 2018-09-28

Family

ID=56119063

Family Applications (1)

Application Number Title Priority Date Filing Date
MA38411A MA38411B1 (en) 2013-03-14 2014-03-07 Cdc7 inhibitors

Country Status (2)

Country Link
AR (1) AR095016A1 (en)
MA (1) MA38411B1 (en)

Also Published As

Publication number Publication date
MA38411B1 (en) 2018-09-28
AR095016A1 (en) 2015-09-16

Similar Documents

Publication Publication Date Title
BR112015020466A2 (en) cdc7 inhibitors
MA41251B1 (en) Thieno [2,3-c] pyrrol-4-one derivatives as erk inhibitors
EA201591591A1 (en) COMPOUNDS OF CARBAZOLE APPLIED AS Bromodomain Inhibitors
MA39172A1 (en) Heterocyclic bicyclic derivatives as bromodomaine inhibitors
TR201901886T4 (en) DNA-PK inhibitors.
EA202092456A2 (en) COMBINATION THERAPY INCLUDING MDM2 INHIBITOR AND ONE OR MORE ADDITIONAL PHARMACEUTICALLY ACTIVE AGENTS FOR TREATMENT OF VARIOUS TYPES OF CANCER
EA201500362A1 (en) RHO-KINASE INHIBITORS
EA201491391A1 (en) THERAPEUTICALLY ACTIVE COMPOUNDS AND METHODS OF THEIR APPLICATION
EA201691845A1 (en) PHARMACEUTICAL COMPOSITIONS OF THERAPEUTICALLY ACTIVE COMPOUNDS
EA201500393A1 (en) BLUTON TYROSINKINASE INHIBITORS
EA201691844A1 (en) PHARMACEUTICAL COMPOSITIONS OF THERAPEUTICALLY ACTIVE COMPOUNDS
EA201690513A1 (en) COMBINATION OF MEK INHIBITOR AND ERK INHIBITOR FOR USE IN THE TREATMENT OF HYPERPROLIFERATIVE DISEASES
FR3021970B1 (en) ANTIBODY AGAINST GALECTIN 9 AND INHIBITOR OF THE SUPPRESSIVE ACTIVITY OF T REGULATORY LYMPHOCYTES
MX2016003823A (en) A selective inhibitor of phosphatidylinositol 3-kinase-gamma.
EA201690039A1 (en) RORC2 INHIBITORS AND METHODS OF THEIR APPLICATION
TR201901348T4 (en) Pyrrolidinone derivatives as metap-2 inhibitors.
EA201690783A1 (en) SUBSTANCES, PHARMACEUTICAL COMPOSITION AND METHODS OF APPLICATION IN THE TREATMENT OF INFLAMMATORY DISEASES
EA201791933A1 (en) INHIBITION OF OLIG2 ACTIVITY
MA42776B1 (en) Compounds useful for inhibiting t-ror
EA201390499A1 (en) COMPOUNDS SUITABLE FOR THE INHIBITION OF CHK1
EA201990508A1 (en) ACTIVITY INHIBITION Olig2
TR201908151T4 (en) Isoindoline derivatives.
MX2016008968A (en) Organic compounds.
EA201990413A1 (en) METHOD OF TREATING HEPATIC ENCEPHALOPATHY
MX2018006631A (en) Compound for use in the prevention and treatment of neurodegenerative diseases.